Clinical Trials Directory

Trials / Unknown

UnknownNCT04927117

Evaluation of Visual Acuity in Myopic Cataract Patients Using Trifocal Intraocular Lens

Evaluation of Binocular Visual Acuity in Myopic Cataract Patients Using Trifocal Intraocular Lens : a 2 Years Prospective, Observational, Multi-center Study

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Aier School of Ophthalmology, Central South University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The PanOptix trifocal IOL is a new trifocal intraocular lens which is proved to provide good range of vision for distance, intermediate and near and good visual quality in cataract patients with normal axial length. But whether it can get the same visual quality in myopia is still unknown

Detailed description

There are a few publications of multi-focal IOLs on Chinese patients with high myopia. From published papers, it is known that performance of multifocal IOLs is satisfied in myopic patients. However there is no publication to investigate PanOptix in moderate and high myopic patients. So it is imperative to demonstrate good performance of PanOptix in those special patients. The purpose of this study is to assess visual performance and patient satisfaction after the implantation of PanOptix in myopic patients.

Conditions

Timeline

Start date
2020-07-01
Primary completion
2022-07-01
Completion
2023-07-01
First posted
2021-06-15
Last updated
2021-06-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04927117. Inclusion in this directory is not an endorsement.

Evaluation of Visual Acuity in Myopic Cataract Patients Using Trifocal Intraocular Lens (NCT04927117) · Clinical Trials Directory